Key result
Transcatheter secundum ASD closure achieves complete RV normalization in ~77% of successful cases.
Why the study?
Does transcatheter device closure compared to surgical closure safely and effectively treat secundum type atrial septal defect in patients > 2 years of age?
Does transcatheter device closure compared to surgical closure safely and effectively treat secundum type atrial septal defect in patients > 2 years of age?
Both interventional catheterization and surgical intracardiac repair are safe and effective options for closing secundum type atrial septal defects, with no in-hospital mortality observed.
Supports transcatheter closure feasibility in secundum ASD; extends observational RV data but leaves open randomized surgery comparisons.
This single centre retrospective analysis presents data from 611 patients with ASD closure. Included were patients > 2 years of age. Patients presented at a median [range] age of 6,95 [2 - 86] years for interventional closure of ASD. Out of 611 patients, 215 underwent intracardiac repair based on transthoracic ECHO-findings. Transcatheter device closure was attempted and successfully performed in 300 out of 396 patients (Amplatzer™ Septal-Occluder (ASO) n = 290 patients). Follow –up was 3.3 years [1 day - 21.8 years] in patients with interventional closure of ASD and 0.7 years [3 days – 14.7 years] (p< 0.001; Mann-Whitney) in patients after surgical closure. There was no in-hospital mortality in both groups. One patient after Amplatzer device closure with absent aortic rim developed erosion that was treated by cardiac surgery and patch closure of ASD. Two patients showed dislocation of the device. In 231 out of 396 patients right ventricular dimension normalized completely as determined on last follow-up visit. Six patients at a median age of 60 [49.4 – 68.7] years presented with atrial fibrillation which persisted after ASD closure. 26 patients (6.6%) showed pulmonary hypertension (PH) one of them presenting with coincidental ASD and severe PH. Closure of ASD II can be accomplished safely by interventional catheterization and intracardiac repair. In most cases per-operative transthoracic and transesophageal echocardiography is sufficient to decide whether a surgical approach or interventional closure is the best option to close the defect.
No takes yet. Share an insight, caveat, or question.
Gorenflo et al. (2026) studied this question. Transcatheter device closure was successfully performed in 300 out of 396 patients with secundum type atrial septal defect, with 231 showing complete normalization of right ventricular dimension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: